免疫生物研究所の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/18 | 976 | 998 | 974 | 989 | -2 | -0.2% | 134,000 |
2018/05/17 | 996 | 1,022 | 984 | 991 | +1 | +0.1% | 178,300 |
2018/05/16 | 966 | 990 | 934 | 990 | +25 | +2.6% | 236,600 |
2018/05/15 | 1,002 | 1,007 | 961 | 965 | -43 | -4.3% | 257,600 |
2018/05/14 | 1,010 | 1,018 | 994 | 1,008 | +2 | +0.2% | 125,200 |
2018/05/11 | 1,000 | 1,006 | 982 | 1,006 | +4 | +0.4% | 123,400 |
2018/05/10 | 996 | 1,017 | 991 | 1,002 | +11 | +1.1% | 136,300 |
2018/05/09 | 1,044 | 1,045 | 981 | 991 | -62 | -5.9% | 330,200 |
2018/05/08 | 1,017 | 1,067 | 1,017 | 1,053 | +27 | +2.6% | 183,800 |
2018/05/07 | 1,025 | 1,047 | 1,016 | 1,026 | -20 | -1.9% | 126,400 |
2018/05/02 | 1,038 | 1,055 | 1,015 | 1,046 | +30 | +3% | 175,100 |
2018/05/01 | 1,039 | 1,065 | 1,011 | 1,016 | -4 | -0.4% | 260,900 |
2018/04/27 | 1,060 | 1,064 | 1,006 | 1,020 | -50 | -4.7% | 457,000 |
2018/04/26 | 1,074 | 1,138 | 1,058 | 1,070 | -8 | -0.7% | 650,000 |
2018/04/25 | 1,087 | 1,089 | 1,056 | 1,078 | -11 | -1% | 252,900 |
2018/04/24 | 1,091 | 1,115 | 1,082 | 1,089 | -11 | -1% | 197,100 |
2018/04/23 | 1,130 | 1,132 | 1,085 | 1,100 | -20 | -1.8% | 313,800 |
2018/04/20 | 1,121 | 1,163 | 1,113 | 1,120 | -10 | -0.9% | 386,000 |
2018/04/19 | 1,170 | 1,190 | 1,117 | 1,130 | -46 | -3.9% | 529,400 |
2018/04/18 | 1,210 | 1,220 | 1,170 | 1,176 | -24 | -2% | 347,000 |
2018/04/17 | 1,216 | 1,255 | 1,165 | 1,200 | -32 | -2.6% | 570,500 |
2018/04/16 | 1,299 | 1,322 | 1,230 | 1,232 | -67 | -5.2% | 555,900 |
2018/04/13 | 1,326 | 1,358 | 1,286 | 1,299 | -21 | -1.6% | 407,400 |
2018/04/12 | 1,360 | 1,375 | 1,305 | 1,320 | -60 | -4.3% | 551,000 |
2018/04/11 | 1,441 | 1,476 | 1,351 | 1,380 | -51 | -3.6% | 516,600 |
2018/04/10 | 1,424 | 1,462 | 1,382 | 1,431 | -17 | -1.2% | 750,300 |
2018/04/09 | 1,341 | 1,475 | 1,336 | 1,448 | +118 | +8.9% | 1,674,100 |
2018/04/06 | 1,367 | 1,388 | 1,300 | 1,330 | -7 | -0.5% | 563,400 |
2018/04/05 | 1,411 | 1,439 | 1,337 | 1,337 | -80 | -5.6% | 810,400 |
2018/04/04 | 1,480 | 1,520 | 1,386 | 1,417 | -60 | -4.1% | 1,273,400 |
2018/04/03 | 1,360 | 1,518 | 1,355 | 1,477 | +87 | +6.3% | 2,485,900 |
2018/04/02 | 1,432 | 1,548 | 1,368 | 1,390 | -70 | -4.8% | 2,634,700 |
2018/03/30 | 1,253 | 1,482 | 1,241 | 1,460 | +221 | +17.8% | 2,804,800 |
2018/03/29 | 1,331 | 1,350 | 1,238 | 1,239 | -111 | -8.2% | 1,215,900 |
2018/03/28 | 1,323 | 1,390 | 1,270 | 1,350 | -3 | -0.2% | 1,745,300 |
2018/03/27 | 1,390 | 1,445 | 1,325 | 1,353 | -7 | -0.5% | 2,292,400 |
2018/03/26 | 1,200 | 1,440 | 1,169 | 1,360 | +143 | +11.8% | 5,294,200 |
2018/03/23 | 1,230 | 1,261 | 1,178 | 1,217 | -72 | -5.6% | 3,519,200 |
2018/03/22 | 1,027 | 1,320 | 1,009 | 1,289 | +269 | +26.4% | 6,839,700 |
2018/03/20 | 972 | 1,035 | 950 | 1,020 | +18 | +1.8% | 487,500 |
2018/03/19 | 1,067 | 1,067 | 966 | 1,002 | -65 | -6.1% | 750,200 |
2018/03/16 | 1,029 | 1,099 | 1,006 | 1,067 | +37 | +3.6% | 808,000 |
2018/03/15 | 1,050 | 1,070 | 1,020 | 1,030 | -41 | -3.8% | 391,600 |
2018/03/14 | 1,071 | 1,115 | 1,040 | 1,071 | -7 | -0.6% | 692,400 |
2018/03/13 | 1,028 | 1,083 | 1,017 | 1,078 | +45 | +4.4% | 586,400 |
2018/03/12 | 1,043 | 1,059 | 1,008 | 1,033 | -11 | -1.1% | 582,000 |
2018/03/09 | 1,067 | 1,133 | 1,030 | 1,044 | +4 | +0.4% | 1,582,400 |
2018/03/08 | 1,108 | 1,114 | 1,035 | 1,040 | -93 | -8.2% | 1,521,700 |
2018/03/07 | 1,073 | 1,133 | 1,061 | 1,133 | +150 | +15.3% | 2,492,000 |
2018/03/06 | 914 | 1,016 | 912 | 983 | +84 | +9.3% | 708,000 |
1701~
1750
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「免疫生物」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
免疫生物 | 47,800円 | +13.4% | +44.0% | 0.00% | 20.71倍 | 3.33倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
DWTI | 10,100円 | -15.1% | - | 0.00% | - | 6.24倍 |
|
三重大学発創薬ベンチャー。プロテインキナーゼ阻害剤開発技術はじめ眼病治療薬開発に集中 |
DELTA-P | 46,900円 | - | - | 0.00% | - | 14.53倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
VIS | 67,400円 | +306.2% | - | 0.00% | 26.02倍 | 1.98倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
リボミック | 8,400円 | - | - | 0.00% | - | 1.14倍 |
|
東大発の創薬ベンチャー。RNA(リボ核酸)を利用した分子標的薬(アプタマー医薬)を開発 |
市場注目の銘柄
チャート関連のコラム